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Acylation of salmon calcitonin modulates in vitro intestinal peptide flux through membrane permeability enhancement
Acylation of peptide drugs with fatty acid chains has proven beneficial for prolonging systemic circulation, as well as
increasing enzymatic stability and interactions with lipid cell membranes. Thus, acylation offers several potential benefits
for oral delivery of therapeutic peptides, and we hypothesize that tailoring the acylation may be used to optimize intestinal
translocation. This work aims to characterize acylated analogues of the therapeutic peptide salmon calcitonin (sCT), which
lowers blood calcium, by systematically increasing acyl chain length at two positions, in order to elucidate its influence on
intestinal cell translocation and membrane interaction. We find that acylation drastically increases in vitro intestinal peptide
flux and confers a transient permeability enhancing effect on the cell layer. The analogues permeabilize model lipid
membranes, indicating that the effect is due to a solubilization of the cell membrane, similar to transcellular oral
permeation enhancers. The effect is dependent on pH, with larger effect at lower pH, and is impacted by acylation chain
length and position. Compared to the unacylated peptide backbone, N-terminal acylation with a short chain provides 6- or
9-fold increase in peptide translocation at pH 7.4 and 5.5, respectively. Prolonging the chain length appears to hamper
translocation, possibly due to self-association or aggregation, although the long chain acylated analogues remain superior
to the unacylated peptide. For K(18)-acylation a short chain provides a moderate improvement, whereas medium and long
chain analogues are highly efficient, with a 12-fold increase in permeability compared to the unacylated peptide backbone,
on par with currently employed oral permeation enhancers. For K18-acylation the medium chain acylation appears to be
optimal, as elongating the chain causes greater binding to the cell membrane but similar permeability, and we speculate
that increasing the chain length further may decrease the permeability. In conclusion, acylated sCT acts as its own in vitro
intestinal permeation enhancer, with reversible effects on Caco-2 cells, indicating that acylation of sCT may represent a
promising tool to increase intestinal permeability without adding oral permeation enhancers. 
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